Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Cisplatin in Recurrent or Metastatic Head and Neck Cancer
NCT00030576Phase 2Completed
- Sponsor
- University Health Network
- Start
- Nov 2001
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University Health Network. Started Nov 2001; status: completed.
02
Drugs
erlotinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00030576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030576.